Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-α-2b in patients with advanced gastric carcinoma

S. Wadler, B. Gleissner, R. U. Hilgenfeld, E. Thiel, H. Haynes, R. Kaleya, A. Rozenblit, E. D. Kreuser

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-α-2b in patients with advanced gastric carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences